David McClung
Chief Financial Officer
Replay available
BioCardia, Inc. (NASDAQ: BCDA) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Analyst, Brookline Capital Markets
Investor Relations
Analyst, Alliance Global Partners
President and Chief Executive Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Biocardia, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.056 Good afternoon and welcome to the BioCardia third quarter financial results 00:00:05.056 -- 00:00:10.321 and business update conference call. All participants will be in listen-only mode. 00:00:10.321 -- 00:00:15.085 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.085 -- 00:00:20.771 key followed by zero. After today's presentation, there will be an opportunity 00:00:20.771 -- 00:00:22.672 to ask questions. 00:00:22.672 -- 00:00:27.997 To ask a question, you may press star then one on your touch screen 00:00:27.997 -- 00:00:34.092 or keypad. To withdraw your question, please press star, then two. 00:00:34.092 -- 00:00:38.916 Participants of this call are advised that the audio of this conference call is being 00:00:38.916 -- 00:00:44.701 broadcast live over the internet and is also being recorded for playback purposes. 00:00:44.701 -- 00:00:49.865 A webcast replay of the call will be available approximately one hour after the 00:00:49.865 -- 00:00:55.891 end of the call. I would now like to turn the call over to Miranda Pato of BioCardia 00:00:55.891 -- 00:00:59.819 Investor Relations. Please go ahead, Miranda. 00:00:59.819 -- 00:01:05.428 Thank you. Good afternoon, and thank you for participating in today's conference call. 00:01:05.428 -- 00:01:10.837 Joining me from BioCardia's leadership team are Peter Altman, President and Chief Executive 00:01:10.837 -- 00:01:16.206 Officer, and David McClung, the company's Chief Financial Officer. 00:01:16.206 -- 00:01:21.334 During this call, management will be making forward-looking statements, including statements 00:01:21.334 -- 00:01:24.339 that address BioCardia's expectations 00:01:24.339 -- 00:01:30.303 for future performance and operat...